Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
TransMolecular, Inc. is a biotechnology company committed to discovering, developing, and commercializing novel, targeted therapies that promise to improve outcomes for gliomas, metastatic brain tumors, and other aggressive cancers with limited treatment options. Our mission: To extend survival and preserve quality of life for millions of cancer patients by providing therapies and delivery technologies that exclusively target malignant cells while avoiding interaction with normal, healthy cells. Company background – Founded in July 1996, TransMolecular is a privately held company backed by venture capital. Since its inception, the company has raised $42.8 million through three private placements from internationally recognized investment ( www.transmolecular.com )
TransMolecular , Inc.
840 Memorial Drive Second Floor
Cambridge, Massachusetts 02139
USA
Tel: (617) 995-3050
Fax: (617) 995-3049